Delivery Order SPE2DB22D1103-SPE2DB25FH0D2
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,633.20 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Febuxostat 80 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the vendor's corporate office in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 5, 2025, for the supply of Febuxostat 40 mg tablets (30-count units) with a ceiling value of $2,139.55. This is a firm fixed-price, non-set-aside contract with performance expected at the company's Conshohocken, Pennsylvania facility and completion by August 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and SAM.gov-registered federal vendor, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $4,598.46 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count packages) on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price delivery order represents a non-set-aside award made through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,273.53 on July 28, 2025, for the supply of Febuxostat 80 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,419.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets in quantities of 30, with an ultimate completion date of September 3, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a $4,615.48 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30, with completion targeted for September 19, 2025. The contract was awarded on a non-competitive basis and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete pharmaceutical procurement action supporting federal...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 4,563,472,907 units of febuxostat 40 mg tablets, with a potential value of $1,659.19. The delivery order has a completion date of January 30, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will deliver these pharmaceutical products from its Corporate Office location in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Febuxostat 40 mg tablets. The $2,437.82 firm fixed-price contract has an ultimate completion date of December 7, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Febuxostat 80 mg tablets (30-count units) with a contract value of $2,965.04. The contract features firm fixed pricing and carries an ultimate completion date of August 26, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $2,255.44 to provide the drug Febuxostat 40 mg Tablet 30s. The contract has an ultimate completion date of February 14, 2024 and was awarded on February 13, 2024 by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...